← HB870 bill details

Substantive final action

HB870

House Vote on HB 870 FINAL PASSAGE (#466)

Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)

Passed House April 13, 2026⭐ Substantive final action

96Yea
0Nay
0Not voting
9Absent

Yea (96)

Absent (9)

Source provenance